Access cutting-edge end-stage kidney disease treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access end-stage kidney disease specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related end-stage kidney disease treatment provided free
The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainab
Sponsor: VA Office of Research and Development
Check if you qualify for this end-stage kidney disease clinical trial in Iowa City, IA
If you're searching for end-stage kidney disease treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end-stage kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.